15
Participants
Start Date
June 19, 2023
Primary Completion Date
June 24, 2024
Study Completion Date
June 24, 2024
Quinine
Quinine, which is a bitter compound, extracted from the bark of the cinchona tree and has been shown in our previous studies to lower blood glucose in doses of 300-600 mg, will be 'active' in this condition.
L-isoleucine
L-isoleucine, which is a branched-chain amino acid, and one of the building blocks of protein, therefore is part of our daily diet, will be 'active' in this condition.
Combination of quinine and L-isoleucine
In this condition, both quinine and L-isoleucine will be administered as 'active'.
Control
"In the condition, where quinine is 'active', control for L-isoleucine (5 ml oraplus and 95 ml saline) will be administered. In the condition, where L-isoleucine will be 'active', control for quinine (10 ml distilled water) will be administered.~Whereas, in a control condition, both for quinine and L-isoleucine, a control solution will be administered."
Clinical Research Facility, Adelaide Health and Medical Sciences Building, Adelaide
University of Adelaide
OTHER